CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test...
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen...
California Agenda: Keep J.P. Morgan, Compete for Jobs
Weeks after 8,000+ biopharma executives and investors descended on San Francisco for J.P. Morgan’s 42nd Annual Healthcare Conference, it remains to be seen where next year’s event will occur. Fueling concern is the exodus...
Scenes from SLAS: AI, Organs-on-Chips Resonate at Record Lab Automation Show
BOSTON–A record attendance of 7,549 scientists, pharma executives, and vendors—lots of vendors—left Boston this week feeling positive about the event and the state of the industry more broadly.
AI, organoids, and organs-on-chips were three of...
New fossil site of worldwide importance uncovered in southern France
Nearly 400 exceptionally well-preserved fossils dating back 470 million years have been discovered in the south of France by two amateur paleontologists. This new fossil site of worldwide importance has been analyzed by scientists...
Study evaluates large language models for autocontouring in head and neck radiotherapy
A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time, and an AI algorithm...
Breaking through barriers
Researchers from Tokyo Medical and Dental University (TMDU) overcome scientific roadblocks and develop a model to assess the biology of the human placental barrier
Credit: Department of Diagnostic and Therapeutic Systems Engineering, TMDU
Researchers from Tokyo...
Tiny device could help improve safety, effectiveness of cell therapy for spinal cord injury...
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal...
New treatment target found for CDKL5 deficiency disorder
Scientists at the Francis Crick Institute have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy. CDD causes seizures and impaired development in children,...
Ultragenyx’s Gene Therapy Ameliorates Pediatric Neurodegenerative Disorder
Heather Lau, MD, is an expert in mucopolysaccharidoses (MPS), having dedicated much of her career as a pediatric neurologist to treating patients with these rare inherited lysosomal storage diseases.
As the director of New York...
Inexpensive, carbon-neutral biofuels are finally possible
When it comes to making fuel from plants, the first step has always been the hardest — breaking down the plant matter. A new study finds that introducing a simple, renewable chemical to the...
